Powdery pharmaceutical composition for nasal administration
US4613500A · kind A · utility
248Cited by
23References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 9, 1984 |
| Grant date | Sep 23, 1986 |
| Priority date | — |
| Expiry date | Mar 9, 2004 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/38
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
What is provided by this invention is a powdery pharmaceutical composition for nasal administration comprising physiologically active polypeptide or its derivative such as calcitonin, insulin, etc. and a water-absorbing and water-insoluble base. The pharmaceutical composition allows polypeptide or its derivative to be efficiently absorbed through the nasal macous membrane when it is nasally administered.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.